基于临床价值的药物风险投资评价体系研究

Research on the evaluation system for drug venture capital based on clinical value

本文从临床价值角度,构建药物风险投资评价体系。收集并整理有关药物临床价值评估的研究文献,结合专家咨询和问卷调查,采用因子分析法建立了具有应用价值的评估体系并确定指标权重。该评价体系由药物治疗价值、药物需求价值、药物市场价值、药物基础价值4个主要指标和依从性、经济学评价、创新程度等16个二级指标构成。风险投资人更为关注药物以临床价值为基础的市场化运作潜力。

To construct the evaluation system of drug venture capital from the perspective of clinical value.The literature related to the clinical value evaluation of drugs was collected and sorted out.Combining with expert consultation and questionnaire survey,an evaluation system with application value was established by means of factor analysis and the index weight was determined.The evaluation system was composed of four primary indicators,including the value of drug treatment,the value of drug demand,the market value of drug,the basic value of drug,and 16 secondary indicators,including compliance,economic evaluation,and innovation degree,and so on.Venture capitalists are more concerned about the marketing potential of drugs based on their clinical value.